Proteasome inhibitor MG132 potentiates TRAIL-induced apoptosis in gallbladder carcinoma GBC-SD cells via DR5-dependent pathway | |
Zhu, Weiping; Zhan, Dihua; Wang, Lu; Ma, Dening; Cheng, Mingrong; Wang, Huipeng; Zhao, Jiaying; Cai, Yuankun; Cheng, Zhijian | |
刊名 | ONCOLOGY REPORTS
![]() |
2016 | |
卷号 | 36期号:2 |
关键词 | gallbladder cancer proteasome inhibitor TRAIL DR5 apoptosis |
ISSN号 | 1021-335X |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4640320 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Zhu, Weiping,Zhan, Dihua,Wang, Lu,et al. Proteasome inhibitor MG132 potentiates TRAIL-induced apoptosis in gallbladder carcinoma GBC-SD cells via DR5-dependent pathway[J]. ONCOLOGY REPORTS,2016,36(2). |
APA | Zhu, Weiping.,Zhan, Dihua.,Wang, Lu.,Ma, Dening.,Cheng, Mingrong.,...&Cheng, Zhijian.(2016).Proteasome inhibitor MG132 potentiates TRAIL-induced apoptosis in gallbladder carcinoma GBC-SD cells via DR5-dependent pathway.ONCOLOGY REPORTS,36(2). |
MLA | Zhu, Weiping,et al."Proteasome inhibitor MG132 potentiates TRAIL-induced apoptosis in gallbladder carcinoma GBC-SD cells via DR5-dependent pathway".ONCOLOGY REPORTS 36.2(2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论